Literature DB >> 19112422

Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3.

S Zhang1, X Cai, F Huang, W Zhong, Z Yu.   

Abstract

AIM: To investigate the influence of trichostatin A (TSA) on inhibition of cell proliferation and induction of apoptosis in human pancreatic cancer cells.
METHODS: MTT-based cytotoxicity assay was used to evaluate the cell viability after treatment with TSA. Cell cycle distribution and apoptosis were examined by means of flow cytometry. Expression of microRNA was determined with microRNA array. Expression of miR-200c and miR-21 was detected by Northern blotting.
RESULTS: TSA significantly inhibited the proliferation of BxPC-3 human pancreatic cancer cells in a time- and dose-dependent manner. BxPC-3 cells treated with TSA were arrested in G0/G1 phase and were characterized by increased apoptotic rate, accompanied by differential expression of microRNAs.
CONCLUSIONS: The results suggest that TSA may activate expression of microRNAs that may act as tumor suppressor in human pancreatic cancer cell line BxPC-3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112422

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  15 in total

1.  Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429.

Authors:  Zhen Lin; Xia Wang; Claire Fewell; Jennifer Cameron; Qinyan Yin; Erik K Flemington
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

Review 2.  Targeting microRNAs in pancreatic cancer: microplayers in the big game.

Authors:  Sheema Khan; Deepak Kumar; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

Review 3.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

4.  TGF-β induces miR-30d down-regulation and podocyte injury through Smad2/3 and HDAC3-associated transcriptional repression.

Authors:  Lin Liu; Wenjun Lin; Qin Zhang; Wangsen Cao; Zhihong Liu
Journal:  J Mol Med (Berl)       Date:  2015-10-03       Impact factor: 4.599

5.  MicroRNAs in pancreatic ductal adenocarcinoma.

Authors:  Jong Y Park; James Helm; Domenico Coppola; Donghwa Kim; Mokenge Malafa; Seung Joon Kim
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

6.  The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.

Authors:  Lyndsay V Rhodes; Ashley M Nitschke; H Chris Segar; Elizabeth C Martin; Jennifer L Driver; Steven Elliott; Seung Yoon Nam; Meng Li; Kenneth P Nephew; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Rep       Date:  2011-10-04       Impact factor: 3.906

Review 7.  MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.

Authors:  Satyanarayana Rachagani; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2009-12-09       Impact factor: 8.679

Review 8.  Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.

Authors:  Daniel Neureiter; Tarkan Jäger; Matthias Ocker; Tobias Kiesslich
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

9.  Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses.

Authors:  Wei Jiang; Xiaowen Chen; Mingzhi Liao; Wei Li; Baofeng Lian; Lihong Wang; Fanlin Meng; Xinyi Liu; Xiujie Chen; Yan Jin; Xia Li
Journal:  Sci Rep       Date:  2012-02-21       Impact factor: 4.379

10.  Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors.

Authors:  Geneviève P Delcuve; Dilshad H Khan; James R Davie
Journal:  Clin Epigenetics       Date:  2012-03-12       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.